Latest GREAT POINT PARTNERS LLC Stock Portfolio
GREAT POINT PARTNERS LLC Performance:
2024 Q3: -0.15%YTD: 10.03%2023: 5.9%
Performance for 2024 Q3 is -0.15%, and YTD is 10.03%, and 2023 is 5.9%.
About GREAT POINT PARTNERS LLC and 13F Hedge Fund Stock Holdings
GREAT POINT PARTNERS LLC is a hedge fund based in GREENWICH, CT. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.9 Billions. In it's latest 13F Holdings report, GREAT POINT PARTNERS LLC reported an equity portfolio of $339.8 Millions as of 30 Sep, 2024.
The top stock holdings of GREAT POINT PARTNERS LLC are , , PLRX. The fund has invested 12.4% of it's portfolio in NEUROGENE INC and 7.2% of portfolio in ABIVAX SA.
The fund managers got completely rid off INSMED INC (INSM), AMICUS THERAPEUTICS INC (FOLD) and ESPERION THERAPEUTICS INC NE (ESPR) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), UROGEN PHARMA LTD (URGN) and DIANTHUS THERAPEUTICS INC. GREAT POINT PARTNERS LLC opened new stock positions in ORUKA THERAPEUTICS INC, UNICYCIVE THERAPEUTICS INC (UNCY) and PROMIS NEUROSCIENCES INC (PMN). The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), OLEMA PHARMACEUTICALS INC (OLMA) and TSCAN THERAPEUTICS INC (TCRX).
The top stock holdings of GREAT POINT PARTNERS LLC are , , PLRX. The fund has invested 12.4% of it's portfolio in NEUROGENE INC and 7.2% of portfolio in ABIVAX SA.
The fund managers got completely rid off INSMED INC (INSM), AMICUS THERAPEUTICS INC (FOLD) and ESPERION THERAPEUTICS INC NE (ESPR) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), UROGEN PHARMA LTD (URGN) and DIANTHUS THERAPEUTICS INC. GREAT POINT PARTNERS LLC opened new stock positions in ORUKA THERAPEUTICS INC, UNICYCIVE THERAPEUTICS INC (UNCY) and PROMIS NEUROSCIENCES INC (PMN). The fund showed a lot of confidence in some stocks as they added substantially to VIRIDIAN THERAPEUTICS INC (VRDN), OLEMA PHARMACEUTICALS INC (OLMA) and TSCAN THERAPEUTICS INC (TCRX).
GREAT POINT PARTNERS LLC Annual Return Estimates Vs S&P 500
Our best estimate is that GREAT POINT PARTNERS LLC made a return of -0.15% in the last quarter. In trailing 12 months, it's portfolio return was 38.36%.
New Buys
| Ticker | $ Bought |
|---|---|
| oruka therapeutics inc | 12,614,300 |
| unicycive therapeutics inc | 3,491,220 |
| promis neurosciences inc | 3,488,370 |
| cartesian therapeutics inc | 3,224,000 |
| eliem therapeutics inc | 1,263,180 |
New stocks bought by GREAT POINT PARTNERS LLC
Additions
| Ticker | % Inc. |
|---|---|
| viridian therapeutics inc | 50.00 |
| olema pharmaceuticals inc | 25.49 |
| tscan therapeutics inc | 8.03 |
Additions to existing portfolio by GREAT POINT PARTNERS LLC
Reductions
| Ticker | % Reduced |
|---|---|
| arcellx inc | -79.67 |
| urogen pharma ltd | -73.89 |
| dianthus therapeutics inc | -63.72 |
| vistagen therapeutics inc | -55.92 |
| evolus inc | -52.28 |
| merus n v | -52.23 |
| dynavax technologies corp | -44.14 |
| voyager therapeutics inc | -40.06 |
GREAT POINT PARTNERS LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| esperion therapeutics inc ne | -12,857,300 |
| amicus therapeutics inc | -14,835,400 |
| puma biotechnology inc | -4,846,130 |
| terns pharmaceuticals inc | -7,827,460 |
| kyverna therapeutics inc | -3,743,640 |
| insmed inc | -16,750,000 |
| spyre therapeutics inc | -3,164,730 |
| lexicon pharmaceuticals inc | -50,400 |
GREAT POINT PARTNERS LLC got rid off the above stocks
Sector Distribution
GREAT POINT PARTNERS LLC has about 67.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 67.6 |
| Others | 32.4 |
Market Cap. Distribution
GREAT POINT PARTNERS LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 36.1 |
| UNALLOCATED | 35.5 |
| MID-CAP | 14.4 |
| MICRO-CAP | 11 |
| NANO-CAP | 3.1 |
Stocks belong to which Index?
About 46.8% of the stocks held by GREAT POINT PARTNERS LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 53.2 |
| RUSSELL 2000 | 46.8 |
GREAT POINT PARTNERS LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC has 29 stocks in it's portfolio. About 58.1% of the portfolio is in top 10 stocks. URGN proved to be the most loss making stock for the portfolio. EOLS was the most profitable stock for GREAT POINT PARTNERS LLC last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 2.46 | 100,000 | 8,351,000 | reduced | -79.67 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANAB | anaptysbio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 3.00 | 2,811,960 | 10,207,400 | reduced | -18.3 | ||
| CNTX | context therapeutics inc | 4.00 | 6,934,980 | 13,592,600 | reduced | -6.53 | ||
| CYTK | cytokinetics inc | 4.91 | 316,000 | 16,684,800 | reduced | -33.36 | ||
| DVAX | dynavax technologies corp | 4.35 | 1,326,230 | 14,774,200 | reduced | -44.14 | ||
| ELYM | eliem therapeutics inc | 0.37 | 248,168 | 1,263,180 | new | |||
| EOLS | evolus inc | 5.58 | 1,170,000 | 18,954,000 | reduced | -52.28 | ||
| ESPR | esperion therapeutics inc ne | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FOLD | amicus therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IONS | ionis pharmaceuticals inc | 3.01 | 255,000 | 10,215,300 | reduced | -22.73 | ||
| JSPR | jasper therapeutics inc | 1.78 | 322,380 | 6,063,970 | reduced | -19.81 | ||
| KALV | kalvista pharmaceuticals inc | 4.43 | 1,299,500 | 15,048,200 | reduced | -2.92 | ||
| LXRX | lexicon pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRUS | merus n v | 3.68 | 250,000 | 12,490,000 | reduced | -52.23 | ||
| OLMA | olema pharmaceuticals inc | 3.51 | 1,000,000 | 11,940,000 | added | 25.49 | ||
| OPTN | optinose inc | 2.54 | 12,861,100 | 8,616,960 | reduced | -6.31 | ||
| OTLK | outlook therapeutics inc | 2.03 | 1,293,030 | 6,904,770 | reduced | -24.01 | ||